THE RELATIONSHIP BETWEEN TSH LEVELS, THYROID AUTOANTIBODIES AND ATHEROGENIC INDEX OF PLASMA, AST TO PLATELET RATIO INDEX SCORE, AND FIBROSIS 4 INDEX IN PATIENTS WITH HYPOTHYROIDISM

被引:1
作者
Demirhan, S. [1 ]
Polat, O. [1 ]
Mert, M. [2 ]
机构
[1] Univ Hlth Sci, Bakirkoy Dr Sadi Konuk Training & Res Hosp, Dept Family Med, TR-31147 Istanbul, Turkiye
[2] Univ Hlth Sci, Bakirkoy Dr Sadi Konuk Training & Res Hosp, Dept Endocrinol & Metab, Istanbul, Turkiye
关键词
Hypothyroidism; AIP; NAFLD; APRI Score; FIB-4; Index; Autoimmunity; FATTY LIVER-DISEASE; SUBCLINICAL HYPOTHYROIDISM; STIMULATING HORMONE; METABOLIC SYNDROME; RISK-FACTOR; DYSFUNCTION; IMPACT;
D O I
10.4183/aeb.2023.333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context. Thyroid hormones have metabolic effects such as relationship between hypothyroidism and atherosclerosis. Objective. Evaluate the effects of hypothyroidism on Non -Alcoholic Fatty Liver Disease and atherosclerosis by using AIP, APRI score, FIB -4 indices. Material and Methods. 1370 patients with hypothyroidism who applied to the Endocrinology and Metabolism outpatient clinic between 01.01.2017-30.12.2021 were included the study. Pregnants, patients with a history of thyroid carcinoma, cardiovascular and liver diseases were excluded. TSH, fT4, Anti TPO, Anti TG, thrombocyte, ALT, AST, HDL, Triglyceride values of the cases were analyzed and atherogenic index of plasma (AIP), AST to Platelet Ratio Index (APRI) and Fibrosis -4 (FIB -4) indices were calculated. Results. 1170 (85.4%) of the cases were female.The age of those who had high risk of AIP was found to be higher than those with low and moderate risk (p=0.001; p=0.003; p<0.01). The ages of those who had low -risk FIB -4 Index were found to be lower than those with moderate risk and high risk (p=0.001; p=0.001; p<0.01). A positive relationship was detected between APRI and FIB -4 (r=0.681; p=0.001; p<0.01).AIP increased as TSH increased in hypothyroid patients. No significant correlations were detected between TSH, APRI, and the FIB -4 Index. No significant differences were detected between AIP, APRI, FIB -4, and thyroid autoantibodies. Conclusion. In hypothyroid patients, the AIP index increased with age and the increase in TSH. A strong relationship was detected between AIP and TSH . For this reason, we think that keeping TSH within the normal range with regular follow-ups and treatment in patients with hypothyroidism will reduce the risk of atherosclerosis.
引用
收藏
页码:333 / 338
页数:6
相关论文
共 50 条
  • [21] Association between the atherogenic index of plasma and coronary collateral circulation in patients with chronic total occlusion
    Dong, Shutong
    Qiao, Jiaming
    Gao, Ang
    Zhao, Zehao
    Huang, Xin
    Kan, Yi
    Yang, Zhiqiang
    Ma, Meishi
    Fan, Chu
    Han, Hongya
    Zhou, Yujie
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [22] Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease
    Huang, Cheryl
    Seah, Jun Jie
    Tan, Chin Kimg
    Kam, Jia Wen
    Tan, Jessica
    Teo, Eng Kiong
    Kwek, Andrew
    Wong, Yu Jun
    Tan, Malcolm
    Ang, Tiing Leong
    Kumar, Rahul
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (04)
  • [23] The role of the AST-to-platelet ratio index (APRI) score on outcomes following robotic minor, technically major, & major hepatectomy for liver tumors
    Cameron Syblis
    Maria Christodoulou
    Sharona Ross
    Tara Menon Pattilachan
    Alexander Rosemurgy
    Iswanto Sucandy
    Journal of Robotic Surgery, 19 (1)
  • [24] Relationship between the Visceral Adiposity Index and neutrophil/lymphocyte ratio in patients with bipolar disorder
    Sahin, Sengul K.
    Simsek, Lutfiye
    Aksoy, Perihan G.
    Elboga, Gulcin
    Altindag, Abdurrahman
    Keskek, Sakir O.
    MINERVA PSYCHIATRY, 2021, 62 (01): : 5 - 11
  • [25] Association between fibrosis-4 index and cognitive impairment in elderly patients with hypertension: A cross-sectional study
    Ding, Hong
    Wang, Jingtao
    Liu, Shu
    Xie, Yafei
    Zhang, Xiaowei
    Yu, Jing
    JOURNAL OF CLINICAL HYPERTENSION, 2024, 26 (11) : 1246 - 1255
  • [26] Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study
    Valérie Martel-Laferrière
    Roy Nitulescu
    Joseph Cox
    Curtis Cooper
    Mark Tyndall
    Danielle Rouleau
    Sharon Walmsley
    Leo Wong
    Marina B. Klein
    BMC Infectious Diseases, 17
  • [27] Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study
    Martel-Laferriere, Valerie
    Nitulescu, Roy
    Cox, Joseph
    Cooper, Curtis
    Tyndall, Mark
    Rouleau, Danielle
    Walmsley, Sharon
    Wong, Leo
    Klein, Marina B.
    BMC INFECTIOUS DISEASES, 2017, 17
  • [28] Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns' index in chronic hepatitis C virus
    Alboraie, Mohamed
    Khairy, Marwa
    Elsharkawy, Marwa
    Asem, Noha
    Elsharkawy, Aisha
    Esmat, Gamal
    HEPATOLOGY RESEARCH, 2015, 45 (05) : 560 - 570
  • [29] Aspartate aminotransferase-to-platelet ratio index outperforms Fibrosis-4 in 2843 Korean patients with metabolic dysfunction-associated steatotic liver disease
    Jang, Se Young
    Yoon, Ki Tae
    Cho, Young Youn
    Jo, Hoon Gil
    Baek, Yang Hyun
    Moon, Sang Yi
    Jo, Ae Jeong
    Kweon, Young-Oh
    Park, Soo Young
    Lee, Yu Rim
    Jun, Dae Won
    Tak, Won Young
    HEPATOLOGY RESEARCH, 2024,
  • [30] Fibrosis score 4 index has an independent relationship with coronary artery diseases in patients with metabolic-associated fatty liver disease
    Namakchian, Maryam
    Rabizadeh, Soghra
    Seifouri, Sara
    Asadigandomani, Hassan
    Bafrani, Melika Arab
    Seifouri, Kiana
    Avanaki, Foroogh Alborzi
    Rajab, Armin
    Nakhjavani, Manouchehr
    Esteghamati, Alireza
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01)